The Effects of Probiotic and Selenium Co-supplementation on Clinical and Metabolic Scales in Chronic Schizophrenia: a Randomized, Double-blind, Placebo-Controlled Trial
Tóm tắt
Từ khóa
Tài liệu tham khảo
Seeman MV (2007) Symptoms of schizophrenia: normal adaptations to inability. Med Hypotheses 69(2):253–257
Kaplan HI (2005) Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, (2 Volume Set, 2005)
Chowdari KV, Bamne MN, Nimgaonkar VL (2011) Genetic association studies of antioxidant pathway genes and schizophrenia. Antioxid Redox Signal 15(7):2037–2045
Rabinowitz J et al (2012) Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE data. Schizophr Res 137(1–3):147–150
Yao JK, Keshavan MS (2011) Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view. Antioxid Redox Signal 15(7):2011–2035
Bloch MH (2009) Trichotillomania across the life span. J Am Acad Child Adolesc Psychiatry 48(9):879–883
Marek GJ et al (2010) Glutamatergic (N-methyl-D-aspartate receptor) hypofrontality in schizophrenia: too little juice or a miswired brain? Mol Pharmacol 77(3):317–326
Kaneko K (2018) Negative symptoms and cognitive impairments in schizophrenia: two key symptoms negatively influencing social functioning. Yonago Acta Med 61(2):91–102
MacKenzie NE et al (2018) Antipsychotics, metabolic adverse effects, and cognitive function in schizophrenia. Front Psychiatry 9:622
Hamer S, Haddad PM (2007) Adverse effects of antipsychotics as outcome measures. Br J Psychiatry Suppl 50:s64–s70
Lewis R (2004) Should cognitive deficit be a diagnostic criterion for schizophrenia? J Psychiatry Neurosci 29(2):102–113
Li Z et al (2018) Association of elements with schizophrenia and intervention of selenium supplements. Biol Trace Elem Res 183(1):16–21
Cai L et al (2015) Serum trace element differences between Schizophrenia patients and controls in the Han Chinese population. Sci Rep 5:15013
Lovell MA et al (2009) Organoselenium (Sel-Plex diet) decreases amyloid burden and RNA and DNA oxidative damage in APP/PS1 mice. Free Radic Biol Med 46(11):1527–1533
Amirani E et al (2020) The effects of probiotic supplementation on mental health, biomarkers of inflammation and oxidative stress in patients with psychiatric disorders: a systematic review and meta-analysis of randomized controlled trials. Complement Ther Med 49:102361
Sayyah M, Andishmand M, Ganji R (2018) Effect of selenium as an adjunctive therapy in patients with treatment-resistant obsessive-compulsive disorder: a pilot randomized double blind placebo-controlled clinical trial. Archives of Psychiatry & Psychotherapy 20(4)
Kryscio RJ et al (2017) Association of antioxidant supplement use and dementia in the Prevention of Alzheimer’s Disease by Vitamin E and Selenium Trial (PREADViSE). JAMA Neurol 74(5):567–573
Ng QX et al (2019) A systematic review of the effect of probiotic supplementation on schizophrenia symptoms. Neuropsychobiology 78(1):1–6
Kim YK, Shin C (2018) The microbiota-gut-brain axis in neuropsychiatric disorders: pathophysiological mechanisms and novel treatments. Curr Neuropharmacol 16(5):559–573
Dickerson FB et al (2014) Effect of probiotic supplementation on schizophrenia symptoms and association with gastrointestinal functioning: a randomized, placebo-controlled trial. Prim Care Companion CNS Disord 16:1
Akkasheh G et al (2016) Clinical and metabolic response to probiotic administration in patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial. Nutrition 32(3):315–320
Mattmiller SA, Carlson BA, Sordillo LM (2013) Regulation of inflammation by selenium and selenoproteins: impact on eicosanoid biosynthesis. J Nutr Sci 2:e28
Ghoneim MA, Moselhy SS (2016) Antioxidant status and hormonal profile reflected by experimental feeding of probiotics. Toxicol Ind Health 32(4):741–750
Carvalho BM, Saad MJ (2013) Influence of gut microbiota on subclinical inflammation and insulin resistance. Mediators Inflamm 2013:986734
Nido SA et al (2016) Effects of selenium-enriched probiotics on lipid metabolism, antioxidative status, histopathological lesions, and related gene expression in mice fed a high-fat diet. Biol Trace Elem Res 171(2):399–409
Ibrahim HA et al (2012) Selenium-enriched probiotics improves murine male fertility compromised by high fat diet. Biol Trace Elem Res 147(1–3):251–260
Tamtaji OR et al (2019) Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer’s disease: a randomized, double-blind, controlled trial. Clin Nutr 38(6):2569–2575
Risch SC et al (2007) Double-blind donepezil-placebo crossover augmentation study of atypical antipsychotics in chronic, stable schizophrenia: a pilot study. Schizophr Res 93(1–3):131–135
Lachar D et al (1999) Use of BPRS-A percent change scores to identify significant clinical improvement: accuracy of treatment response classification in acute psychiatric inpatients. Psychiatry Res 89(3):259–268
Benzie IF, Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem 239(1):70–76
Beutler E, Gelbart T (1985) Plasma glutathione in health and in patients with malignant disease. J Lab Clin Med 105(5):581–584
Janero DR (1990) Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 9(6):515–540
Tatsch E et al (2011) A simple and inexpensive automated technique for measurement of serum nitrite/nitrate. Clin Biochem 44(4):348–350
Pisprasert V et al (2013) Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans. Diabetes Care 36(4):845–853
Stefanska E et al (2017) Eating habits and nutritional status of patients with affective disorders and schizophrenia. Psychiatr Pol 51(6):1107–1120
Vaddadi KS, Soosai E, Vaddadi G (2003) Low blood selenium concentrations in schizophrenic patients on clozapine. Br J Clin Pharmacol 55(3):307–309
Dickerson F et al (2010) Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia. Biol Psychiatry 68(1):100–104
De Hert M et al (2011) Prevalence and severity of antipsychotic related constipation in patients with schizophrenia: a retrospective descriptive study. BMC Gastroenterol 11:17
Tomasik J et al (2015) Immunomodulatory effects of probiotic supplementation in schizophrenia patients: a randomized, placebo-controlled trial. Biomark Insights 10:47–54
Severance EG et al (2017) Probiotic normalization of Candida albicans in schizophrenia: a randomized, placebo-controlled, longitudinal pilot study. Brain Behav Immun 62:41–45
Ghaderi A et al (2019) Clinical and metabolic response to vitamin D plus probiotic in schizophrenia patients. BMC Psychiatry 19(1):77
Diaz Heijtz R et al (2011) Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A 108(7):3047–3052
O'Mahony SM et al (2009) Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry 65(3):263–267
Xie Y et al (2018) Se-methylselenocysteine ameliorates neuropathology and cognitive deficits by attenuating oxidative stress and metal dyshomeostasis in Alzheimer model mice. Mol Nutr Food Res 62(12):e1800107
Zhang ZH et al (2017) Long-term dietary supplementation with selenium-enriched yeast improves cognitive impairment, reverses synaptic deficits, and mitigates tau pathology in a triple transgenic mouse model of Alzheimer’s disease. J Agric Food Chem 65(24):4970–4979
Rayman M et al (2006) Impact of selenium on mood and quality of life: a randomized, controlled trial. Biol Psychiatry 59(2):147–154
Cryan JF, Dinan TG (2012) Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13(10):701–712
Bested AC, Logan AC, Selhub EM (2013) Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: Part I - autointoxication revisited. Gut Pathog 5(1):5
Suvisaari J, Mantere O (2013) Inflammation theories in psychotic disorders: a critical review. Infect Disord Drug Targets 13(1):59–70
Uttara B et al (2009) Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 7(1):65–74
Flatow J, Buckley P, Miller BJ (2013) Meta-analysis of oxidative stress in schizophrenia. Biol Psychiatry 74(6):400–409
Bolisetty S, Jaimes EA (2013) Mitochondria and reactive oxygen species: physiology and pathophysiology. Int J Mol Sci 14(3):6306–6344
Bitanihirwe BK, Woo TU (2011) Oxidative stress in schizophrenia: an integrated approach. Neurosci Biobehav Rev 35(3):878–893
Wang Z et al (2017) Association between C-reactive protein and risk of schizophrenia: An updated meta-analysis. Oncotarget 8(43):75445–75454
Pedrini M et al (2012) Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity. J Psychiatr Res 46(6):819–824
Vaghef-Mehrabany E et al (2014) Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis. Nutrition 30(4):430–435
Mohammadi AA et al (2016) The effects of probiotics on mental health and hypothalamic-pituitary-adrenal axis: A randomized, double-blind, placebo-controlled trial in petrochemical workers. Nutr Neurosci 19(9):387–395
Tamtaji OR et al (2018) Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer’s disease: a randomized, double-blind, controlled trial. Clin Nutr
Liu Y et al (2015) Protective effects of Selenium-enriched probiotics on carbon tetrachloride-induced liver fibrosis in rats. J Agric Food Chem 63(1):242–249
Duntas LH (2009) Selenium and inflammation: underlying anti-inflammatory mechanisms. Horm Metab Res 41(6):443–447
Cohen D et al (2006) Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders. Diabetes Care 29(4):786–791
Lund BC et al (2001) Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach. Arch Gen Psychiatry 58(12):1172–1176
van Beveren NJ et al (2014) Evidence for disturbed insulin and growth hormone signaling as potential risk factors in the development of schizophrenia. Transl Psychiatry 4:e430
Protopopova D et al (2014) Peripheral endothelial dysfunction as a marker of cardiovascular risk in physically healthy patients with schizophrenia and related psychoses: a matched case control study. Neuro Endocrinol Lett 35(6):503–509
Pillinger T et al (2017) Cholesterol and triglyceride levels in first-episode psychosis: systematic review and meta-analysis. Br J Psychiatry 211(6):339–349
Taha AY et al (2013) Altered fatty acid concentrations in prefrontal cortex of schizophrenic patients. J Psychiatr Res 47(5):636–643
Jayawardena R et al (2012) Effects of zinc supplementation on diabetes mellitus: a systematic review and meta-analysis. Diabetol Metab Syndr 4(1):13
Faure P et al (1995) Lipid peroxidation in insulin-dependent diabetic patients with early retina degenerative lesions: effects of an oral zinc supplementation. Eur J Clin Nutr 49(4):282–288
Li C et al (2016) Effect of probiotics on metabolic profiles in type 2 diabetes mellitus: a meta-analysis of randomized, controlled trials. Medicine (Baltimore) 95(26):e4088
Bahmani F et al (2016) Effect of selenium supplementation on glycemic control and lipid profiles in patients with diabetic nephropathy. Biol Trace Elem Res 172(2):282–289
Shimizu M et al (2015) Meta-Analysis: Effects of probiotic supplementation on lipid profiles in normal to mildly hypercholesterolemic individuals. PLoS One 10(10):e0139795
Kim JE et al (2012) Selenium significantly inhibits adipocyte hypertrophy and abdominal fat accumulation in OLETF rats via induction of fatty acid beta-oxidation. Biol Trace Elem Res 150(1–3):360–370
Hsieh FC et al (2013) Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats. Nutr Metab (Lond) 10(1):35